Journal of Gynecologic Oncology

cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer

By Mika Okazawa-Sakai, Takao Fujisawa, Tatsuyuki Chiyoda, Daisuke Aoki

Trial in 35 peopleMechanisms

Cohort study, registered UMIN000036749

The paper

Shikoku Cancer Center; Keio University

Journal of Gynecologic Oncology, 27 Jul 2026

doi.org/10.3802/jgo.2027.38.e11 PubMed 42565794

Nature Genetics4 Oct 2026
Germline HRD limits therapy-driven clonal hematopoiesis
EMBO Reports2 Oct 2026
UHRF1 levels drive distinct senescent states in zebrafish liver cells
International Journal of Molecular Sciences4 Oct 2026
Donor TET2 variant linked to lower stem cell transplant survival
HemaSphere7 Oct 2026
Blood-cell mutation patterns linked to cancer progression